| Product Code: ETC6744063 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Gestational Diabetes Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Gestational Diabetes Market Revenues & Volume, 2021 & 2031F |
3.3 China Gestational Diabetes Market - Industry Life Cycle |
3.4 China Gestational Diabetes Market - Porter's Five Forces |
3.5 China Gestational Diabetes Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 China Gestational Diabetes Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 China Gestational Diabetes Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 China Gestational Diabetes Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 China Gestational Diabetes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gestational diabetes in China |
4.2.2 Rising awareness about the importance of early diagnosis and treatment of gestational diabetes |
4.2.3 Technological advancements in diagnostic tools and treatment options for gestational diabetes |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas of China |
4.3.2 Cultural factors leading to stigma associated with gestational diabetes |
4.3.3 Lack of standardized guidelines for the management of gestational diabetes in China |
5 China Gestational Diabetes Market Trends |
6 China Gestational Diabetes Market, By Types |
6.1 China Gestational Diabetes Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Gestational Diabetes Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 China Gestational Diabetes Market Revenues & Volume, By Insulin, 2021- 2031F |
6.1.4 China Gestational Diabetes Market Revenues & Volume, By SGLT-2 inhibitor, 2021- 2031F |
6.1.5 China Gestational Diabetes Market Revenues & Volume, By Alpha-glucosidase inhibitor, 2021- 2031F |
6.1.6 China Gestational Diabetes Market Revenues & Volume, By Other, 2021- 2031F |
6.2 China Gestational Diabetes Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Gestational Diabetes Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 China Gestational Diabetes Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 China Gestational Diabetes Market Revenues & Volume, By Other, 2021- 2031F |
6.3 China Gestational Diabetes Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Gestational Diabetes Market Revenues & Volume, By Online Channel, 2021- 2031F |
6.3.3 China Gestational Diabetes Market Revenues & Volume, By Offline Channel, 2021- 2031F |
6.4 China Gestational Diabetes Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 China Gestational Diabetes Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 China Gestational Diabetes Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 China Gestational Diabetes Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 China Gestational Diabetes Market Import-Export Trade Statistics |
7.1 China Gestational Diabetes Market Export to Major Countries |
7.2 China Gestational Diabetes Market Imports from Major Countries |
8 China Gestational Diabetes Market Key Performance Indicators |
8.1 Percentage increase in the number of gestational diabetes screenings conducted annually in China |
8.2 Adoption rate of new diagnostic tools and treatment options for gestational diabetes |
8.3 Proportion of healthcare facilities offering specialized care for gestational diabetes in key regions of China |
9 China Gestational Diabetes Market - Opportunity Assessment |
9.1 China Gestational Diabetes Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 China Gestational Diabetes Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 China Gestational Diabetes Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 China Gestational Diabetes Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 China Gestational Diabetes Market - Competitive Landscape |
10.1 China Gestational Diabetes Market Revenue Share, By Companies, 2024 |
10.2 China Gestational Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here